These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20053802)

  • 21. [Should cyproterone acetate be removed from our prescriptions?].
    Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2019 Dec; 47(12):823-824. PubMed ID: 31634588
    [No Abstract]   [Full Text] [Related]  

  • 22. Is cyproterone acetate causing intracranial meningiomas?
    Majid Z; Kareem R
    J Pak Med Assoc; 2022 Oct; 72(10):2144. PubMed ID: 36661024
    [No Abstract]   [Full Text] [Related]  

  • 23. Meningiomas after cyproterone acetate exposure: Case reports in twin sisters.
    de Germay S; Lafaurie M; Dupuy M; de Germay B
    Therapie; 2021; 76(3):255-257. PubMed ID: 32418729
    [No Abstract]   [Full Text] [Related]  

  • 24. Meningioma in patients exposed to progestin drugs: results from a real-life screening program.
    Samoyeau T; Provost C; Roux A; Legrand L; Dezamis E; Plu-Bureau G; Pallud J; Oppenheim C; Benzakoun J
    J Neurooncol; 2022 Oct; 160(1):127-136. PubMed ID: 36066786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intra cranial meningiomas and long term use of cyproterone acetate with a conventional dose in women. A report of two cases of tumor decrease after treatment withdrawal].
    Botella C; Coll G; Lemaire JJ; Irthum B
    Neurochirurgie; 2015 Oct; 61(5):339-42. PubMed ID: 26249273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia.
    Mallari R; Sinclair RD
    Int J Dermatol; 2002 Dec; 41(12):946-7. PubMed ID: 12492998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Meningioma under progestin treatment : what attitude to adopt ?].
    Cornu E; Pintiaux A; Reuter G; Kridelka F; Pétrossians P; Potorac I
    Rev Med Liege; 2023 Oct; 78(10):550-557. PubMed ID: 37830319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracranial meningiomas in patients with uterine sarcoma treated with long-term megestrol acetate therapy.
    Gruber TJ; Fabiano AJ; Deeb G; Lele SB; Fenstermaker RA
    World Neurosurg; 2011 Nov; 76(5):477.e16-20. PubMed ID: 22152580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meningiomas in three male-to-female transgender subjects using oestrogens/progestogens and review of the literature.
    Ter Wengel PV; Martin E; Gooren L; Den Heijer M; Peerdeman SM
    Andrologia; 2016 Dec; 48(10):1130-1137. PubMed ID: 26888610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients.
    Bernat AL; Oyama K; Hamdi S; Mandonnet E; Vexiau D; Pocard M; George B; Froelich S
    Acta Neurochir (Wien); 2015 Oct; 157(10):1741-6. PubMed ID: 26264069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal therapies and meningioma: is there a link?
    Cea-Soriano L; Blenk T; Wallander MA; Rodríguez LA
    Cancer Epidemiol; 2012 Apr; 36(2):198-205. PubMed ID: 21943794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report.
    Champagne PO; Passeri T; Froelich S
    Acta Neurochir (Wien); 2019 Mar; 161(3):589-592. PubMed ID: 30666456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender-affirming hormone therapy associated with multiple meningiomas and atypical histology in a transgender woman.
    Millward CP; Phillips E; Alalade AF; Gilkes CE
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34261631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of androgenic alopecia by minoxidil: lack of effect of simultaneously administered intermediate doses of cyproterone acetate.
    Vermorken AJ
    Acta Derm Venereol; 1983; 63(3):268-9. PubMed ID: 6192653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual.
    Bergoglio MT; Gómez-Balaguer M; Almonacid Folch E; Hurtado Murillo F; Hernández-Mijares A
    Endocrinol Nutr; 2013 May; 60(5):264-7. PubMed ID: 23022362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained growth of intraosseous hormone-associated meningiomas after cessation of progestin therapy.
    AbiJaoude S; Marijon P; Roblot P; Tran S; Cornu P; Kalamarides M; Peyre M
    Acta Neurochir (Wien); 2021 Jun; 163(6):1705-1710. PubMed ID: 33649877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant.
    Piper JG; Follett KA; Fantin A
    Neurosurgery; 1994 Apr; 34(4):723-5; discussion 725. PubMed ID: 8008172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dramatic Shrinkage with Reduced Vascularization of Large Meningiomas After Cessation of Progestin Treatment.
    Kalamarides M; Peyre M
    World Neurosurg; 2017 May; 101():814.e7-814.e10. PubMed ID: 28300711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration.
    Shimizu J; Matsumoto M; Yamazaki E; Yasue M
    Neurol Med Chir (Tokyo); 2008 May; 48(5):227-30. PubMed ID: 18497498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal therapy for fertility and huge meningioma: a purely random association?
    Frassanito P; De Bonis P; Mattogno PP; Novello M; Anile C
    Acta Neurol Belg; 2012 Sep; 112(3):299-301. PubMed ID: 22426675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.